 NEW YORK, Oct. 01, 2021 GLOBE NEWSWIRE -- Scopus BioPharma Inc. Nasdaq: SCPS, a clinical-stage biopharmaceutical company, announced today that it is retaining Boies Schiller Flexner LLP to conduct a market manipulation investigation. 